Xconomy | Life Sciences - Business + Technology in the Exponential Economy

Wireless Health, people, Life Sciences

west-wireless-health-institute-logo

West Wireless Health Institute Names J&J Exec as First CEO

Bruce V. Bigelow 3/9/10

San Diego’s West Wireless Health Institute today named Donald Casey as its first chief executive officer. Case, a former worldwide chairman of Johnson & Johnson’s Comprehensive Care group, also will serve on the institute’s board of directors, according to a statement issued today.

Gary West, who sold his Omaha, NE-based West Corp. for $3.3 billion in 2006, founded the institute almost exactly a year ago with a $45 million gift from... Read more »

Biotech, people, startups

iStock_000000219187XSmall

The 20-Year Future of San Diego Biotech, Coming March 31

Luke Timmerman 3/9/10

A wise man once said that overnight success in biotech takes about 15 years. All kidding aside, we at Xconomy recognize that real innovation in life sciences doesn’t just pop out of the blue on a... Read more »

Roundup, deals, VC

Google Buys DocVerse, Madrona Backs ShopIgniter, ISB Gets Mystery Gift, & More Seattle-Area Deals News

Gregory T. Huang 3/9/10

In the week since Google’s acquisition of Picnik, the Northwest deals scene came back to earth a little bit. But there was a decent amount of activity in software, Internet, mobile, and cleantech, much of it... Read more »

Life Sciences, innovation, Drug Development

steve_mayfield

Scientists from Sapphire Energy, UCSD, Scripps, and Protelica Show Genetically Modified Algae Can Make Important Drugs

Bruce V. Bigelow 3/8/10

Scientists in San Diego and Hayward, CA, have demonstrated the feasibility of using algae to produce commercial levels of human therapeutic proteins that are currently being used to treat emphysema and other diseases, or are in... Read more »

Biotech, Hepatitis C, Drugs

vertex1

Vertex Maps Out Combo Drug Game Plan for Treating Hepatitis C

Luke Timmerman 3/8/10

HIV has taught the pharmaceutical industry that the best way to fight an infectious virus that resists a single drug is to make a cocktail that attacks the virus in more than one way. Vertex Pharmaceuticals... Read more »

Biotech, cancer, IT

Dendreon logo

Dendreon Leans on California 9-1-1 Software Vendor to Keep Provenge Trains on Time

Luke Timmerman 3/8/10

If Dendreon makes any information technology screw-ups with its experimental treatment for prostate cancer, it could be a matter of life and death for patients. That’s why the Seattle-based biotech company has turned to a custom... Read more »

Biotech, cancer, Drugs

Cell Therapeutics Offers Execs Big Cash Bonuses As Stock Trades Below a Buck

Luke Timmerman 3/5/10

Biotech, Finances, Antibiotics

Trius Puts the Brakes on IPO Plan, While It Adjusts to New FDA Clinical Guidelines

Luke Timmerman 3/5/10

Life Sciences, medical devices, Obstructive Sleep Apnea

ImThera Medical Generating Buzz Over Neurostimulation for Sleep Apnea

Bruce V. Bigelow 3/5/10

Biotech, Devices, Ultrasound

Ekos, Swedish Aim to Shake Up Stroke Treatment with Ultrasound Brain Clot Buster

Luke Timmerman 3/5/10

Life Sciences, deals, Diagnostics

Una Ryan Searching for Riches to Deliver Inexpensive Diagnostics to the Poor

Ryan McBride 3/5/10

Roundup, Life Sciences, Biotech

Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News

Erin Kutz 3/5/10
More recent posts More

Xconomist Forum - Insight & Opinion

Biotech, Drugs, startups

The Pharmaceutical R&D Model is Broken. Here’s How to Fix It

Stewart Lyman 3/5/10

Research is the lifeblood of the biotech and pharmaceuticals business. The pharma and biotech industry spent some $65 billion dollars on R & D in 2008, according to the Pharmaceutical Research... Read more »

Biotech, people, careers

Tips on How Academic Scientists Can Make the Career Switch to Industry

Don Rule 2/25/10

Scientists have a lot to consider if they want to leave the world of academia for a job in industry. I picked up a lot of good insights yesterday at a... Read more »

Mobile Handsets, cleantech, startups

How EcoATM Became San Diego’s Hottest Startup Deal, If I Say So Myself

Mark Bowles 2/17/10

For a company that was founded by three wireless industry veterans only about a year ago, ecoATM ended 2009 with some pretty impressive results. If there was a yearbook for San... Read more »

Life Sciences, Jobs, Economy

Why Biomedical Jobs Are Recession Resilient

David Gollaher 2/12/10

Biomedical employment has held remarkably steady in San Diego and throughout California, even though other parts of our economy saw steep declines and the highest unemployment levels since the Great Depression.... Read more »

Biotech, people, Global Health

Why Biotech Innovators Are Beating a Path to Seattle

Chris Rivera 2/12/10

As the life sciences sector continues to navigate the changing seas of innovation in the new economy, we’ve trained our gaze toward a few beacons. Seattle and the Pacific Northwest have... Read more »

IPOs, law, management

Ready, Set, Go Public—The 10 Things You Need to Do Now

David Westenberg 2/11/10

The IPO market is open for business. The IPO market window has slammed shut. Which is it? Unless your IPO is pricing in the next week or two, it doesn’t matter.... Read more »

Biotech, incubators, startups

Seattle Needs an “Incubator” Culture

Matthew Scholz 2/4/10

Life Sciences, Big Pharma, China

What Lies Ahead for San Diego Life Sciences

Jim Pope 2/1/10

Biotech, Global Health, people

Synchronicity is Not Just an Album by The Police. Nor is Serendipity Just a John Cusack movie.

Richard Gayle 2/1/10

Biotech, Genomics, Global Health

Genomics Laid the Foundation for Big Global Health Advances To Come This Decade

Ken Stuart 1/21/10

Biotech, Diagnostics, Personalized Medicine

Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade?

Matthew O'Donnell 1/15/10

Biotech, Genomics, cancer

Five Disruptive Biotech Ideas to Watch in the Coming Decade

David Walt 1/8/10
More Xconomist posts More
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.